Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma

Several biological and clinical considerations suggest the involvement of cyclooxygenase-2 (COX-2), the key enzyme of prostaglandin (PG) synthesis, in the pathogenesis and progression of haematological malignancies. Despite the wealth of data concerning COX-2 expression, only limited information is...

Full description

Saved in:
Bibliographic Details
Main Authors: Trojan, Andreas (Author) , Tinguely, Marianne (Author) , Vallet, Sonia (Author) , Seifert, Burkhardt (Author) , Jenni, Bettina (Author) , Zippelius, Alfred (Author) , Witzens-Harig, Mathias (Author) , Mechtersheimer, Gunhild (Author) , Ho, Anthony Dick (Author) , Goldschmidt, Hartmut (Author) , Jäger, Dirk (Author) , Boccadoro, Mario (Author) , Ladetto, Marco (Author)
Format: Article (Journal)
Language:English
Published: [2006]
In: Swiss medical weekly
Year: 2006, Volume: 136, Issue: 25/26, Pages: 400-403
ISSN:1424-3997
Online Access:Verlag, lizenzpflichtig, Volltext: https://serval.unil.ch/resource/serval:BIB_F68233E85238.P001/REF
Get full text
Author Notes:Andreas Trojan, Marianne Tinguely, Sonia Vallet, Burkhardt Seifert, Bettina Jenni, Alfred Zippelius, Mathias Witzens-Harig, Gunhild Mechtersheimer, Anthony D. Ho, Hartmut Goldschmidt, Dirk Jäger, Mario Boccadoro, Marco Ladetto

MARC

LEADER 00000caa a2200000 c 4500
001 1789610109
003 DE-627
005 20230426075808.0
007 cr uuu---uuuuu
008 220215s2006 xx |||||o 00| ||eng c
035 |a (DE-627)1789610109 
035 |a (DE-599)KXP1789610109 
035 |a (OCoLC)1341441697 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Trojan, Andreas  |e VerfasserIn  |4 aut 
245 1 0 |a Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma  |c Andreas Trojan, Marianne Tinguely, Sonia Vallet, Burkhardt Seifert, Bettina Jenni, Alfred Zippelius, Mathias Witzens-Harig, Gunhild Mechtersheimer, Anthony D. Ho, Hartmut Goldschmidt, Dirk Jäger, Mario Boccadoro, Marco Ladetto 
264 1 |c [2006] 
300 |b Illustrationen 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.02.2022 
520 |a Several biological and clinical considerations suggest the involvement of cyclooxygenase-2 (COX-2), the key enzyme of prostaglandin (PG) synthesis, in the pathogenesis and progression of haematological malignancies. Despite the wealth of data concerning COX-2 expression, only limited information is available on multiple myeloma (MM). Using standard immunohistochemistry we therefore evaluated COX-2 protein expression in samples from 57 patients with a primary diagnosis of MM. Time to progression and a variety of clinicopathological features were evaluated by the Kaplan-Meier method and the Cox regression model. In addition, COX-2 expression was evaluated by staining bone marrow from healthy donors and 11 patients with MGUS. Overall, 31 MM samples (54%) expressed COX-2. Positivity for COX-2 was unrelated to stage or clinical or molecular features of the disease. However, patients with COX-2 positive tumours experienced a significantly shorter time to progression (17 vs 30 months, p = 0.037). In summary, COX-2 is frequently expressed in MM and correlates with shorter progression-free survival. 
650 4 |a Adult 
650 4 |a Aged 
650 4 |a Aged, 80 and over 
650 4 |a Cyclooxygenase 2 
650 4 |a Disease Progression 
650 4 |a Female 
650 4 |a Humans 
650 4 |a Immunohistochemistry 
650 4 |a Male 
650 4 |a Middle Aged 
650 4 |a Multiple Myeloma 
650 4 |a Proportional Hazards Models 
650 4 |a Survival Analysis 
700 1 |a Tinguely, Marianne  |e VerfasserIn  |4 aut 
700 1 |a Vallet, Sonia  |e VerfasserIn  |4 aut 
700 1 |a Seifert, Burkhardt  |e VerfasserIn  |4 aut 
700 1 |a Jenni, Bettina  |e VerfasserIn  |4 aut 
700 1 |a Zippelius, Alfred  |e VerfasserIn  |4 aut 
700 1 |a Witzens-Harig, Mathias  |e VerfasserIn  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 aut 
700 1 |a Mechtersheimer, Gunhild  |e VerfasserIn  |0 (DE-588)1021953024  |0 (DE-627)715842595  |0 (DE-576)170441598  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Boccadoro, Mario  |e VerfasserIn  |4 aut 
700 1 |a Ladetto, Marco  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Swiss medical weekly  |d Basel : EMH Schweizerischer Ärzteverl., 1996  |g 136(2006), 25/26, Seite 400-403  |h Online-Ressource  |w (DE-627)324825811  |w (DE-600)2031164-3  |w (DE-576)281199329  |x 1424-3997  |7 nnas  |a Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma 
773 1 8 |g volume:136  |g year:2006  |g number:25/26  |g pages:400-403  |g extent:4  |a Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma 
856 4 0 |u https://serval.unil.ch/resource/serval:BIB_F68233E85238.P001/REF  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220215 
993 |a Article 
994 |a 2006 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 11 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 10 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 1021953024  |a Mechtersheimer, Gunhild  |m 1021953024:Mechtersheimer, Gunhild  |d 910000  |d 912000  |d 50000  |e 910000PM1021953024  |e 912000PM1021953024  |e 50000PM1021953024  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 8 
998 |g 1050736516  |a Witzens-Harig, Mathias  |m 1050736516:Witzens-Harig, Mathias  |d 910000  |d 910100  |e 910000PW1050736516  |e 910100PW1050736516  |k 0/910000/  |k 1/910000/910100/  |p 7 
999 |a KXP-PPN1789610109  |e 4059932191 
BIB |a Y 
SER |a newspaper 
JSO |a {"language":["eng"],"person":[{"family":"Trojan","display":"Trojan, Andreas","given":"Andreas","role":"aut"},{"family":"Tinguely","display":"Tinguely, Marianne","role":"aut","given":"Marianne"},{"family":"Vallet","display":"Vallet, Sonia","role":"aut","given":"Sonia"},{"family":"Seifert","display":"Seifert, Burkhardt","role":"aut","given":"Burkhardt"},{"given":"Bettina","role":"aut","family":"Jenni","display":"Jenni, Bettina"},{"given":"Alfred","role":"aut","family":"Zippelius","display":"Zippelius, Alfred"},{"display":"Witzens-Harig, Mathias","family":"Witzens-Harig","role":"aut","given":"Mathias"},{"role":"aut","given":"Gunhild","family":"Mechtersheimer","display":"Mechtersheimer, Gunhild"},{"given":"Anthony Dick","role":"aut","display":"Ho, Anthony Dick","family":"Ho"},{"family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"aut","given":"Hartmut"},{"family":"Jäger","display":"Jäger, Dirk","role":"aut","given":"Dirk"},{"role":"aut","given":"Mario","family":"Boccadoro","display":"Boccadoro, Mario"},{"role":"aut","given":"Marco","display":"Ladetto, Marco","family":"Ladetto"}],"id":{"eki":["1789610109"]},"name":{"displayForm":["Andreas Trojan, Marianne Tinguely, Sonia Vallet, Burkhardt Seifert, Bettina Jenni, Alfred Zippelius, Mathias Witzens-Harig, Gunhild Mechtersheimer, Anthony D. Ho, Hartmut Goldschmidt, Dirk Jäger, Mario Boccadoro, Marco Ladetto"]},"physDesc":[{"extent":"4 S.","noteIll":"Illustrationen"}],"relHost":[{"pubHistory":["Nachgewiesen 1996,40 -"],"origin":[{"publisherPlace":"Basel","dateIssuedDisp":"1996-","dateIssuedKey":"1996","publisher":"EMH Schweizerischer Ärzteverl."}],"note":["Gesehen am 13.10.2025","Frühere Jahrgänge online nicht mehr verfügbar"],"title":[{"subtitle":"official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology","title_sort":"Swiss medical weekly","title":"Swiss medical weekly"}],"disp":"Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaSwiss medical weekly","type":{"media":"Online-Ressource","bibl":"newspaper"},"recId":"324825811","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2031164-3"],"issn":["1424-3997"],"eki":["324825811"]},"language":["ger"],"part":{"year":"2006","pages":"400-403","text":"136(2006), 25/26, Seite 400-403","issue":"25/26","volume":"136","extent":"4"},"titleAlt":[{"title":"SMW"},{"title":"Journal suisse de médecine"}]}],"recId":"1789610109","type":{"media":"Online-Ressource","bibl":"article-newspaper"},"note":["Gesehen am 15.02.2022"],"origin":[{"dateIssuedDisp":"[2006]","dateIssuedKey":"2006"}],"title":[{"title_sort":"Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma","title":"Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma"}]} 
SRT |a TROJANANDRCLINICALSI2006